Skip to main content
Erschienen in: Archives of Gynecology and Obstetrics 4/2011

01.10.2011 | Materno-fetal Medicine

The association between inherited thrombophilias and pregnancy-related hypertension recurrence

verfasst von: Inanc Mendilcioglu, Turker Bilgen, Yunus Arikan, Ibrahim Keser, Mehmet Simsek, Aysen Timuragaoglu

Erschienen in: Archives of Gynecology and Obstetrics | Ausgabe 4/2011

Einloggen, um Zugang zu erhalten

Abstract

Purpose

The aim of this study was to determine the association between inherited thrombophilias and pregnancy-related hypertension recurrence.

Methods

In this case–control study, blood samples were obtained from patients who had at least two pregnancies complicated with pregnancy-related hypertension (n = 41) and healthy, normotensive pregnancies delivered without any complication (n = 38). Following the DNA extraction, samples were tested for factor V Leiden, prothrombin G20210A and homozygous methylene tetrahydrofolate reductase (MTHFR) C677T mutations using reverse hybridization method.

Results

Common inherited thrombophilias were present in 26.8% of women with recurrent pregnancy-related hypertension group and 23.7% of control subjects (odds ratio 1.1; 95% confidence interval, 0.6–1.9). No significant difference was observed between two groups in terms of factor V Leiden, prothrombin G20210A and MTHFR C677T mutations.

Conclusion

Our data suggest that factor V Leiden, prothrombin G20210A and MTHFR C677T mutations are not associated with pregnancy-related hypertension recurrence.
Literatur
1.
Zurück zum Zitat American College of Obstetricians, Gynecologists (1996) Hypertension in pregnancy ACOG technical bulletin no: 219. Int J Gynaecol Obstet 53:175–183CrossRef American College of Obstetricians, Gynecologists (1996) Hypertension in pregnancy ACOG technical bulletin no: 219. Int J Gynaecol Obstet 53:175–183CrossRef
2.
Zurück zum Zitat National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy (2000) Report of the national high blood pressure education program working group on high blood pressure in pregnancy. Am J Obstet Gynecol 183:S1–S22CrossRef National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy (2000) Report of the national high blood pressure education program working group on high blood pressure in pregnancy. Am J Obstet Gynecol 183:S1–S22CrossRef
3.
Zurück zum Zitat Hjartardottir S, Leifsson B, Geirsson R, Steinthorsdottir V (2006) Recurrence of hypertensive disorder in second pregnancy. Am J Obset Gynecol 194:916–920CrossRef Hjartardottir S, Leifsson B, Geirsson R, Steinthorsdottir V (2006) Recurrence of hypertensive disorder in second pregnancy. Am J Obset Gynecol 194:916–920CrossRef
4.
Zurück zum Zitat Campell DM, MacGillivray I, Carr-Hill R (1985) Preeclampsia in second pregnancy. Br J Obstet Gynecol 92:131–140CrossRef Campell DM, MacGillivray I, Carr-Hill R (1985) Preeclampsia in second pregnancy. Br J Obstet Gynecol 92:131–140CrossRef
5.
Zurück zum Zitat Trogstad L, Skrondal A, Stoltenberg C, Magnus P, Nesheim B-I, Eskild A (2004) Recurrence risk of preeclampsia in twin and singleton pregnancies. Am J Med Genet A 126:41–45CrossRef Trogstad L, Skrondal A, Stoltenberg C, Magnus P, Nesheim B-I, Eskild A (2004) Recurrence risk of preeclampsia in twin and singleton pregnancies. Am J Med Genet A 126:41–45CrossRef
6.
Zurück zum Zitat Lie RT, Rasmussen S, Brunborg H, Gjessing HK, Lie-Nielsen E, Irgens LM (1998) Fetal and maternal contributions to risk of preeclampsia: population based study. BMJ 316:1343–1347PubMed Lie RT, Rasmussen S, Brunborg H, Gjessing HK, Lie-Nielsen E, Irgens LM (1998) Fetal and maternal contributions to risk of preeclampsia: population based study. BMJ 316:1343–1347PubMed
7.
Zurück zum Zitat Mostello D, Kallogjeri D, Tungsiripat R, Leet T (2008) Recurrence of preeclampsia: effects of gestational age at delivery of the first pregnancy, body mass index, paternity, and interval between births. Am J Obstet Gynecol 199:55.e1–55.e7CrossRef Mostello D, Kallogjeri D, Tungsiripat R, Leet T (2008) Recurrence of preeclampsia: effects of gestational age at delivery of the first pregnancy, body mass index, paternity, and interval between births. Am J Obstet Gynecol 199:55.e1–55.e7CrossRef
8.
Zurück zum Zitat Kupferminc MJ, Eldor A, Steinman N, Many A, Bar-Am A, Jaffa A, Fait G, Lessing JB (1999) Increased frequency of genetic thrombophilia in women with complications of pregnancy. N Engl J Med 340:9–13PubMedCrossRef Kupferminc MJ, Eldor A, Steinman N, Many A, Bar-Am A, Jaffa A, Fait G, Lessing JB (1999) Increased frequency of genetic thrombophilia in women with complications of pregnancy. N Engl J Med 340:9–13PubMedCrossRef
9.
Zurück zum Zitat Dizon-Townson DS, Helson LN, Easton K, Ward K (1996) The factor V Leiden mutation may predispose women to severe preeclampsia. Am J Obstet Gynecol 175:902–905PubMedCrossRef Dizon-Townson DS, Helson LN, Easton K, Ward K (1996) The factor V Leiden mutation may predispose women to severe preeclampsia. Am J Obstet Gynecol 175:902–905PubMedCrossRef
10.
Zurück zum Zitat Grandone E, Margaglione M, Colaizzo D, Cappucci G, Paladini D, Martinelli P, Montanaro S, Pavone G, Di Minno G (1997) Factor V Leiden, C > T MTHFR polymorphism and genetic susceptibility to preeclampsia. Thromb Haemost 77:1052–1054PubMed Grandone E, Margaglione M, Colaizzo D, Cappucci G, Paladini D, Martinelli P, Montanaro S, Pavone G, Di Minno G (1997) Factor V Leiden, C > T MTHFR polymorphism and genetic susceptibility to preeclampsia. Thromb Haemost 77:1052–1054PubMed
11.
Zurück zum Zitat Robertson L, Wu O, Langhorne P, Twaddle S, Clark P, Lowe GD, Walker ID, Greaves M, Brenkel I, Regan L, Greer IA (2006) Thrombosis: risk and economic assessment of thrombophilia screening (treats) study. Thrombophilia in pregnancy: a systematic review. Br J Haematol 132(2):171–196PubMedCrossRef Robertson L, Wu O, Langhorne P, Twaddle S, Clark P, Lowe GD, Walker ID, Greaves M, Brenkel I, Regan L, Greer IA (2006) Thrombosis: risk and economic assessment of thrombophilia screening (treats) study. Thrombophilia in pregnancy: a systematic review. Br J Haematol 132(2):171–196PubMedCrossRef
12.
Zurück zum Zitat Ray JG, Laskin CA (1999) Folic acid and homocyst(e)ine metabolic defects and the risk of placental abruption, pre-eclampsia and spontaneous pregnancy loss: a systematic review. Placenta 20(7):519–29 Ray JG, Laskin CA (1999) Folic acid and homocyst(e)ine metabolic defects and the risk of placental abruption, pre-eclampsia and spontaneous pregnancy loss: a systematic review. Placenta 20(7):519–29
13.
Zurück zum Zitat Dizon-Townson D, Miller C, Sibai B, Spong CY, Thom E, Wendel G Jr, Wenstrom K, Samuels P, Cotroneo MA, Moawad A, Sorokin Y, Meis P, Miodovnik M, O’Sullivan MJ, Conway D, Wapner RJ, Gabbe SG, National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network (2005) The relationship of the factor V Leiden mutation and pregnancy outcomes for mother and fetus. Obstet Gynecol 106:517–524PubMedCrossRef Dizon-Townson D, Miller C, Sibai B, Spong CY, Thom E, Wendel G Jr, Wenstrom K, Samuels P, Cotroneo MA, Moawad A, Sorokin Y, Meis P, Miodovnik M, O’Sullivan MJ, Conway D, Wapner RJ, Gabbe SG, National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network (2005) The relationship of the factor V Leiden mutation and pregnancy outcomes for mother and fetus. Obstet Gynecol 106:517–524PubMedCrossRef
14.
Zurück zum Zitat Kahn SR, Platt R, McNamara H, Rozen R, Chen MF, Genest J Jr, Goulet L, Lydon J, Seguin L, Dassa C, Masse A, Asselin G, Benjamin A, Miner L, Ghanem A, Kramer MS (2009) Inherited thrombophilia and preeclampsia within a multicenter cohort: the Montreal Preeclampsia Study. Am J Obstet Gynecol 200:151.e1–151.e9CrossRef Kahn SR, Platt R, McNamara H, Rozen R, Chen MF, Genest J Jr, Goulet L, Lydon J, Seguin L, Dassa C, Masse A, Asselin G, Benjamin A, Miner L, Ghanem A, Kramer MS (2009) Inherited thrombophilia and preeclampsia within a multicenter cohort: the Montreal Preeclampsia Study. Am J Obstet Gynecol 200:151.e1–151.e9CrossRef
15.
Zurück zum Zitat Facchinetti F, Marozio L, Frusca T, Grandone E, Venturini P, Tiscia GL, Zatti S, Benedetto C (2009) Maternal thrombophilia and the risk of recurrence of preeclampsia. Am J Obstet Gynecol 200:46.e1–46.e5CrossRef Facchinetti F, Marozio L, Frusca T, Grandone E, Venturini P, Tiscia GL, Zatti S, Benedetto C (2009) Maternal thrombophilia and the risk of recurrence of preeclampsia. Am J Obstet Gynecol 200:46.e1–46.e5CrossRef
16.
Zurück zum Zitat van Rijn BB, Hoeks LB, Bots ML, Franx A, Bruinse HW (2006) Outcomes of subsequent pregnancy after first pregnancy with early-onset preeclampsia. Am J Obstet Gynecol 195:723–728PubMedCrossRef van Rijn BB, Hoeks LB, Bots ML, Franx A, Bruinse HW (2006) Outcomes of subsequent pregnancy after first pregnancy with early-onset preeclampsia. Am J Obstet Gynecol 195:723–728PubMedCrossRef
17.
Zurück zum Zitat Askie LM, Duley L, Henderson-Smart DJ, Stewart LA, PARIS Collaborative Group (2007) Antiplatelet agents for prevention of pre-eclampsia: a meta-analysis of individual patient data. Lancet 369:1791–1798PubMedCrossRef Askie LM, Duley L, Henderson-Smart DJ, Stewart LA, PARIS Collaborative Group (2007) Antiplatelet agents for prevention of pre-eclampsia: a meta-analysis of individual patient data. Lancet 369:1791–1798PubMedCrossRef
18.
Zurück zum Zitat Barton JR, Sibai BM (2008) Prediction and prevention of recurrent preeclampsia. Obstet Gynecol 112:359–372PubMedCrossRef Barton JR, Sibai BM (2008) Prediction and prevention of recurrent preeclampsia. Obstet Gynecol 112:359–372PubMedCrossRef
19.
Zurück zum Zitat Rodger MA, Paidas M, McLintock C, Middeldorp S, Kahn S, Martinelli I, Hague W, Rosene Montella K, Greer I (2008) Inherited thrombophilia and pregnancy complications revisited. Obstet Gynecol 112:320–324PubMedCrossRef Rodger MA, Paidas M, McLintock C, Middeldorp S, Kahn S, Martinelli I, Hague W, Rosene Montella K, Greer I (2008) Inherited thrombophilia and pregnancy complications revisited. Obstet Gynecol 112:320–324PubMedCrossRef
20.
Zurück zum Zitat Lin J, August P (2005) Genetic thrombophilias and preeclampsia: a meta-analysis. Obstet Gynecol 105:182–192PubMedCrossRef Lin J, August P (2005) Genetic thrombophilias and preeclampsia: a meta-analysis. Obstet Gynecol 105:182–192PubMedCrossRef
21.
Zurück zum Zitat Alfirevic Z (2002) How strong is the association between maternal thrombophilia and adverse pregnancy outcome? A systematic review. Eur J Obstet Gynecol Reprod Biol 101:6–14PubMedCrossRef Alfirevic Z (2002) How strong is the association between maternal thrombophilia and adverse pregnancy outcome? A systematic review. Eur J Obstet Gynecol Reprod Biol 101:6–14PubMedCrossRef
22.
Zurück zum Zitat Barton JR, O’Brien JM, Bergauer NK, Jacques DL, Sibai BM (2001) Mild gestational hypertension remote from term: progression and outcome. Am J Obstet Gynecol 184:979–983PubMedCrossRef Barton JR, O’Brien JM, Bergauer NK, Jacques DL, Sibai BM (2001) Mild gestational hypertension remote from term: progression and outcome. Am J Obstet Gynecol 184:979–983PubMedCrossRef
Metadaten
Titel
The association between inherited thrombophilias and pregnancy-related hypertension recurrence
verfasst von
Inanc Mendilcioglu
Turker Bilgen
Yunus Arikan
Ibrahim Keser
Mehmet Simsek
Aysen Timuragaoglu
Publikationsdatum
01.10.2011
Verlag
Springer-Verlag
Erschienen in
Archives of Gynecology and Obstetrics / Ausgabe 4/2011
Print ISSN: 0932-0067
Elektronische ISSN: 1432-0711
DOI
https://doi.org/10.1007/s00404-010-1756-y

Weitere Artikel der Ausgabe 4/2011

Archives of Gynecology and Obstetrics 4/2011 Zur Ausgabe

Hirsutismus bei PCOS: Laser- und Lichttherapien helfen

26.04.2024 Hirsutismus Nachrichten

Laser- und Lichtbehandlungen können bei Frauen mit polyzystischem Ovarialsyndrom (PCOS) den übermäßigen Haarwuchs verringern und das Wohlbefinden verbessern – bei alleiniger Anwendung oder in Kombination mit Medikamenten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Weniger postpartale Depressionen nach Esketamin-Einmalgabe

Bislang gibt es kein Medikament zur Prävention von Wochenbettdepressionen. Das Injektionsanästhetikum Esketamin könnte womöglich diese Lücke füllen.

Bei RSV-Impfung vor 60. Lebensjahr über Off-Label-Gebrauch aufklären!

22.04.2024 DGIM 2024 Kongressbericht

Durch die Häufung nach der COVID-19-Pandemie sind Infektionen mit dem Respiratorischen Synzytial-Virus (RSV) in den Fokus gerückt. Fachgesellschaften empfehlen eine Impfung inzwischen nicht nur für Säuglinge und Kleinkinder.

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.